Fidelity Investments
CAMP icon

Fidelity Investments’s CAMP4 Therapeutics CAMP Stock Holding History

Fidelity Investments’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.8M Buy
4,933,432
+15,189
+0.3% +$72.1K ﹤0.01% 1754
2025
Q4 		$30.1M Buy
4,918,243
+1,894,809
+63% +$8.06M ﹤0.01% 1630
2025
Q3 		$9.07M Buy
3,023,434
+2,415,488
+397% +$4.47M ﹤0.01% 2037
2025
Q2 		$882K Sell
607,946
-159,001
-21% -$316K ﹤0.01% 2764
2025
Q1 		$3.07M Buy
766,947
+11,922
+2% +$57.7K ﹤0.01% 2319
2024
Q4 		$3.94M Buy
+755,025
New +$6.2M ﹤0.01% 2240

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Fidelity Investments's CAMP Position: Q1 2026 in Review

Fidelity Investments increased its CAMP4 Therapeutics (CAMP) stake by 0.31% in Q1 2026, buying an estimated $72.1K and bringing the position to 4,933,432 shares worth $21.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

Fidelity Investments first reported a position in CAMP in Q4 2024 and has held it in 6 quarters since. The position peaked at $30.1M in Q4 2025. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Fidelity Investments held 4,933,432 shares of CAMP4 Therapeutics worth $21.8M as of Q1 2026.
  • Fidelity Investments bought 15,189 CAMP4 Therapeutics shares in Q1 2026, an estimated $72.1K.
  • CAMP4 Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1754 holding.
  • Fidelity Investments first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Fidelity Investments's CAMP4 Therapeutics position peaked at $30.1M in Q4 2025.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.